Jason Paul Steik's Stock Options and Common Stock Holdings in Pennant Group, Inc.

The SEC filing details the stock options and common stock holdings of Jason Paul Steik, the Chief Clinical Officer of Pennant Group, Inc. (PNTG). The filing includes multiple stock options granted to Steik, with exercise dates ranging from 2021 to 2026 and expiration dates extending up to 2035. The underlying security for these options is the company's common stock, with varying numbers of shares and exercise prices. Additionally, Steik holds 16,500 shares of common stock directly and 647 shares acquired through open market purchases prior to becoming an officer. The stock options vest in five equal annual installments starting from the first anniversary of the grant date.